Arca Biopharma | ABIO - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 540M 1000K 2026-03
Arca Biopharma USD 48.72M 338K 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Daiichi Sankyo JPY 1.85B 9K 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Laboratory Of America USD 82.3M 100K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
Otsuka Holdings JPY 527.31M 824K 2026-03
Pfizer USD 5.7B 13M 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03